Samantha Peel

AstraZeneca

AstraZeneca
Sam is an Associate Principal Scientist currently working within the Functional Genomics team at AstraZeneca in Cambridge, UK.  My current role is centred around the use of genetic (including CRISPR reagents) and other perturbants to interrogate complex biology and identify new targets for the treatment of different diseases.  I have a particular interest in the application of confocal fluorescent microscopy to develop high content, phenotypic cell & tissue based imaging assays for target identification and validation.  Before joining AstraZeneca in 2010, I held a postdoctoral research position at the University of Nottingham where my work focussed on cell signalling in airway smooth muscle. I have a PhD in cell signalling from the University of Nottingham and a BSc in Pharmacology from the University of Bath.